People Will Become More Accepting Of Jabs: Expert

"); jQuery("#212 h3").html("

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1576240_1_20210218165956.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1576240-20210218.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1576240-20210218.htm', 'DCS.dcsqry', '' ); } } }); }); });
2021-02-18 HKT 17:16
Dr Leung Chi-chiu speaks to Wendy Wong
A specialist in respiratory medicine said on Thursday that he believed more people would be willing to receive coronavirus vaccine once the inoculation programme is rolled out, although various surveys suggested a low acceptance rate.
Previous polls showed only between 30 and 40 per cent of Hong Kong people would get the jabs, but Dr Leung Chi-chiu said he believed their attitude would change over time.
He said he expected the public to become less worried about the vaccine’s safety as more people get inoculated.
“For something new, I think the initial acceptance may be low. That should not be a major issue because the priority groups account for about 2.4 million people. And we only have sufficient vaccine in the initial stage for one million,” he said.
“If we can roll out the programme successfully, I’m certain that the attitude will change with time. As time goes, there will be further data not only from abroad but also from the local application. That should relieve the anxiety of people who might be worried about the vaccine’s safety profile.”
He noted that an expert panel appointed by the government has yet to decide on whether the vaccine produced by mainland drug maker Sinovac can be given to elderly people aged over 60.
He said the decision would affect how quickly protection could be offered to elderly people living in care homes here.
“This is crucial because this vaccine does not require the super cold storage syringe. They can be more easily handled by the outreach teams. If they can be applied for the elderly, they can be quickly utilised to cover our old age homes,” he said.
HashKey Capital Partners With Tiantu AM To Explore Virtual Asset Funds
HashKey Capital has signed a memorandum of strategic collaboration with Tiantu Asset Management (Tiantu AM), a wholly o... Read more
You Can Now Make Alipay Payments With AR Glasses
RayNeo and Ant Group have announced a partnership to develop digital payment solutions for global use. The collaboratio... Read more
JICA Goes Live With Finastras Loan IQ In First Japan Deployment
Finastra has announced that the Japan International Cooperation Agency (JICA) has gone live with its Loan IQ platform. ... Read more
Japan Set To Approve First Yen-Backed Stablecoin
Japan’s Financial Services Agency (FSA) is preparing to approve the issuance of the country’s first yen-backed stab... Read more
Indonesia And China Begin Trials For Cross-Border QRIS Payments
Bank Indonesia (BI) and the People’s Bank of China (PBOC) have begun a series of trials for cross-border QR code paym... Read more
ANZ Appoints Ender Tanar As Japan Country Head
ANZ, headquartered in Melbourne, Australia, announced the appointment of Ender Tanar as Country Head for Japan, reporti... Read more